Decipher Labs Q1 FY27 results: revenue dips, consolidated loss narrows

Revenue declinedNet loss reportedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.4%Reaction day

₹6.34

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-5.4% vs market

Pharmaceuticals peers, median of 166sector-0.4%-5.0% vs sector

On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 5.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.4+0.1-5.4-0.4-5.0

Next day

-7.3+0.2-7.5-0.3-6.9

-7.3+0.6-7.8-0.5-6.7

-11.5-0.0-11.5-1.3-10.2

-7.7+0.5-8.2-0.8-6.9

-9.3+0.8-10.1-0.4-8.9

-10.3+0.6-10.8-0.9-9.4

15d

-5.4+1.3-6.6+0.0-5.4

-5.7-1.4-4.3-0.1-5.6

-3.9-0.6-3.4-2.6-1.3

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 (quarter ended 30 June 2026) standalone and consolidated results. Consolidated revenue from operations fell to Rs 241.39 lakh from Rs 292.37 lakh a year ago. Consolidated net loss was Rs 218.57 lakh versus Rs 342.67 lakh loss in Q1 FY26, but employee costs surged to Rs 275.96 lakh. Standalone revenue plunged to Rs 9.81 lakh from Rs 84.65 lakh, with a standalone loss of Rs 7.93 lakh against a Rs 5.59 lakh profit last year. Board also appointed Mr Bhupendralal Waghray as Additional Independent Director for five years. Auditor Ramanatham and Rao issued an unmodified limited review.

Likely market impact

Weak quarter with revenue decline and continued losses across both standalone and consolidated books, though consolidated loss has narrowed from a year ago.